817
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Homology Model of Human Retinoic Acid Metabolising Enzyme Cytochrome P450 26A1 (CYP26A1): Active Site Architecture and Ligand Binding

, , , , &
Pages 361-369 | Received 01 Mar 2006, Accepted 31 Mar 2006, Published online: 04 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Robert S. Foti, Philippe Diaz & Dominique Douguet. (2016) Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases. Journal of Enzyme Inhibition and Medicinal Chemistry 31:sup2, pages 148-161.
Read now
Jayne E Thatcher & Nina Isoherranen. (2009) The role of CYP26 enzymes in retinoic acid clearance. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 875-886.
Read now
Stephane Pautus, Ahmed S. Aboraia, Claire E. Bassett, Andrea Brancale, Michael P. Coogan & Claire Simons. (2009) Design and synthesis of substituted imidazole and triazole N-phenylbenzo[d]oxazolamine inhibitors of retinoic acid metabolizing enzyme CYP26. Journal of Enzyme Inhibition and Medicinal Chemistry 24:2, pages 487-498.
Read now
J.H. Ren, X.Q. Xiong, Y. Sha, M.C. Yan, B. Lin, J. Wang, Y.K. Jing, D.M. Zhao & M.S. Cheng. (2008) Structure prediction and R115866 binding study of human CYP26A1: homology modelling, fold recognition, molecular docking and MD simulations. Molecular Simulation 34:3, pages 337-346.
Read now

Articles from other publishers (14)

Nina Isoherranen & Guo Zhong. (2019) Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases. Pharmacology & Therapeutics 204, pages 107400.
Crossref
R. S. Foti, N. Isoherranen, A. Zelter, L. J. Dickmann, B. R. Buttrick, P. Diaz & D. Douguet. (2016) Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1. Journal of Pharmacology and Experimental Therapeutics 357:2, pages 281-292.
Crossref
Mohamed Awadalla, Thamir Alshammari, Leif Eriksson & Patricia Saenz-Méndez. (2016) Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1. Molecules 21:3, pages 351.
Crossref
Andrew Millard, David J. Scanlan, Connor Gallagher, Andrew Marsh & Paul C. Taylor. (2014) Unexpected evolutionary proximity of eukaryotic and cyanobacterial enzymes responsible for biosynthesis of retinoic acid and its oxidation. Molecular BioSystems 10:3, pages 380.
Crossref
Fengrong Li, Dongmei Zhao, Jinhong Ren, Feiyue Hao, Guyue Liu, Shengfei Jin, Yongkui Jing & Maosheng Cheng. (2013) 2-(2-Methylfuran-3-carboxamido)-3-phenylpropanoic acid, a potential CYP26A1 inhibitor to enhance all-trans retinoic acid-induced leukemia cell differentiation based on virtual screening and biological evaluation. Bioorganic & Medicinal Chemistry 21:11, pages 3256-3261.
Crossref
Jakob A. Shimshoni, Arthur G. Roberts, Michele Scian, Ariel R. Topletz, Sean A. Blankert, James R. Halpert, Wendel L. Nelson & Nina Isoherranen. (2012) Stereoselective Formation and Metabolism of 4-Hydroxy-Retinoic Acid Enantiomers by Cytochrome P450 Enzymes. Journal of Biological Chemistry 287:50, pages 42223-42232.
Crossref
Patricia Saenz-Méndez, Ali Ateia Elmabsout, Helena Sävenstrand, Mohamed Khalid Alhaj Awadalla, Åke Strid, Allan Sirsjö & Leif A. Eriksson. (2012) Homology Models of Human All-Trans Retinoic Acid Metabolizing Enzymes CYP26B1 and CYP26B1 Spliced Variant. Journal of Chemical Information and Modeling 52:10, pages 2631-2637.
Crossref
Mohamed S. Gomaa, Andrew S.T. Lim, S.C. Wilson Lau, Ann-Marie Watts, Nicola A. Illingworth, Caroline E. Bridgens, Gareth J. Veal, Christopher P.F. Redfern, Andrea Brancale, Jane L. Armstrong & Claire Simons. (2012) Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates. Bioorganic & Medicinal Chemistry 20:20, pages 6080-6088.
Crossref
Puranik Purushottamachar, Jyoti B. Patel, Lalji K. Gediya, Omoshile O. Clement & Vincent C.O. Njar. (2012) First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): Identification of novel RAMBA scaffolds. European Journal of Medicinal Chemistry 47, pages 412-423.
Crossref
Mohamed S. Gomaa, Caroline E. Bridgens, Gareth J. Veal, Christopher P. F. Redfern, Andrea Brancale, Jane L. Armstrong & Claire Simons. (2011) Synthesis and Biological Evaluation of 3-(1 H -Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26) . Journal of Medicinal Chemistry 54:19, pages 6803-6811.
Crossref
Jayne E. Thatcher, Brian Buttrick, Scott A. Shaffer, Jakob A. Shimshoni, David R. Goodlett, Wendel L. Nelson & Nina Isoherranen. (2011) Substrate Specificity and Ligand Interactions of CYP26A1, the Human Liver Retinoic Acid Hydroxylase. Molecular Pharmacology 80:2, pages 228-239.
Crossref
Mohamed S. GomaaCaroline E. BridgensAhmed S. AboraiaGareth J. VealChristopher P. F. RedfernAndrea BrancaleJane L. ArmstrongClaire Simons. (2011) Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26): Synthesis and Biological Evaluation of Imidazole Methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates. Journal of Medicinal Chemistry 54:8, pages 2778-2791.
Crossref
Mohamed Sayed Gomaa, Jane L. Armstrong, Beatrice Bobillon, Gareth J. Veal, Andrea Brancale, Christopher P.F. Redfern & Claire Simons. (2008) Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells. Bioorganic & Medicinal Chemistry 16:17, pages 8301-8313.
Crossref
Magnus Karlsson, Åke Strid, Allan Sirsjö & Leif A. Eriksson. (2008) Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1). Journal of Chemical Theory and Computation 4:6, pages 1021-1027.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.